193 related articles for article (PubMed ID: 26220665)
21. An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction.
Secchiero P; Corallini F; Beltrami AP; Ceconi C; Bonasia V; Di Chiara A; Ferrari R; Zauli G
Atherosclerosis; 2010 May; 210(1):274-7. PubMed ID: 20015493
[TBL] [Abstract][Full Text] [Related]
22. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.
Gottenberg JE; Dayer JM; Lukas C; Ducot B; Chiocchia G; Cantagrel A; Saraux A; Roux-Lombard P; Mariette X
Ann Rheum Dis; 2012 Jul; 71(7):1243-8. PubMed ID: 22532637
[TBL] [Abstract][Full Text] [Related]
23. IL2RA is associated with persistence of rheumatoid arthritis.
van Steenbergen HW; van Nies JA; Ruyssen-Witrand A; Huizinga TW; Cantagrel A; Berenbaum F; van der Helm-van Mil AH
Arthritis Res Ther; 2015 Sep; 17(1):244. PubMed ID: 26350950
[TBL] [Abstract][Full Text] [Related]
24. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
[TBL] [Abstract][Full Text] [Related]
25. Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort.
Le Cornet C; Jung AY; Johnson TS; Behrens S; Obi N; Becher H; Chang-Claude J; Fortner RT
Breast Cancer Res; 2023 Apr; 25(1):42. PubMed ID: 37069615
[TBL] [Abstract][Full Text] [Related]
26. Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.
Koga T; Okada A; Fukuda T; Hidaka T; Ishii T; Ueki Y; Kodera T; Nakashima M; Takahashi Y; Honda S; Horai Y; Watanabe R; Okuno H; Aramaki T; Izumiyama T; Takai O; Miyashita T; Sato S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Aoyagi K; Eguchi K; Kawakami A;
PLoS One; 2017; 12(5):e0175281. PubMed ID: 28505163
[TBL] [Abstract][Full Text] [Related]
27. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
Carrier N; Marotta A; de Brum-Fernandes AJ; Liang P; Masetto A; Ménard HA; Maksymowych WP; Boire G
Arthritis Res Ther; 2016 Feb; 18():37. PubMed ID: 26832367
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas.
Sandra F; Hendarmin L; Nakamura S
Oral Oncol; 2006 Apr; 42(4):415-20. PubMed ID: 16413220
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies.
Castellino G; Corallini F; Trotta F; Secchiero P
Lupus; 2007; 16(7):479-82. PubMed ID: 17670845
[TBL] [Abstract][Full Text] [Related]
31. Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease.
Shaker OG; El-Shehaby A; Nabih M
Angiology; 2010 Nov; 61(8):756-62. PubMed ID: 20498140
[TBL] [Abstract][Full Text] [Related]
32. Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.
Ma JD; Wei XN; Zheng DH; Mo YQ; Chen LF; Zhang X; Li JH; Dai L
Arthritis Res Ther; 2015 Oct; 17():289. PubMed ID: 26467222
[TBL] [Abstract][Full Text] [Related]
33. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis.
Levidou G; Thymara I; Saetta AA; Papanastasiou P; Pavlopoulos P; Sakellariou S; Fragkou P; Patsouris E; Korkolopoulou P
Pathology; 2013 Feb; 45(2):138-44. PubMed ID: 23277172
[TBL] [Abstract][Full Text] [Related]
34. Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis.
Kurz K; Herold M; Russe E; Klotz W; Weiss G; Fuchs D
Dis Markers; 2015; 2015():276969. PubMed ID: 26576067
[TBL] [Abstract][Full Text] [Related]
35. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
[TBL] [Abstract][Full Text] [Related]
36. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
[TBL] [Abstract][Full Text] [Related]
37. Inverse regulation of serum osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand levels in patients with leg lesional vascular calcification: An observational study.
Moon AR; Park Y; Chang JH; Lee SS
Medicine (Baltimore); 2019 Mar; 98(10):e14489. PubMed ID: 30855435
[TBL] [Abstract][Full Text] [Related]
38. Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort.
Vesperini V; Lukas C; Fautrel B; Le Loet X; Rincheval N; Combe B
Arthritis Care Res (Hoboken); 2013 Dec; 65(12):1899-906. PubMed ID: 23836776
[TBL] [Abstract][Full Text] [Related]
39. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
Asanuma Y; Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
Atherosclerosis; 2007 Dec; 195(2):e135-41. PubMed ID: 17570371
[TBL] [Abstract][Full Text] [Related]
40. Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis.
Asanuma YF; Shimada Y; Kouzu N; Yokota K; Nakajima K; Sato K; Akiyama Y; Isozaki M; Mikami AS; Kobayashi H; Mimura T
Mod Rheumatol; 2013 Mar; 23(2):269-75. PubMed ID: 22584471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
